Federated Hermes’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-15,793
Closed -$344K 2246
2016
Q2
$344K Buy
15,793
+10,784
+215% +$235K ﹤0.01% 1373
2016
Q1
$112K Sell
5,009
-20,751
-81% -$464K ﹤0.01% 1556
2015
Q4
$712K Buy
25,760
+930
+4% +$25.7K ﹤0.01% 1197
2015
Q3
$641K Buy
24,830
+2,280
+10% +$58.9K ﹤0.01% 1209
2015
Q2
$559K Buy
22,550
+980
+5% +$24.3K ﹤0.01% 1301
2015
Q1
$544K Buy
21,570
+5,930
+38% +$150K ﹤0.01% 1342
2014
Q4
$367K Sell
15,640
-1,900
-11% -$44.6K ﹤0.01% 1406
2014
Q3
$399K Sell
17,540
-19,970
-53% -$454K ﹤0.01% 1410
2014
Q2
$917K Buy
37,510
+3,110
+9% +$76K ﹤0.01% 1206
2014
Q1
$725K Buy
34,400
+33,920
+7,067% +$715K ﹤0.01% 1246
2013
Q4
$11K Buy
+480
New +$11K ﹤0.01% 1702

Other funds holding QGENF

Federated Hermes's QGENF Position: Q3 2016 in Review

Federated Hermes sold out of QIAGEN NV (QGENF) in Q3 2016, closing a stake of 15,793 shares — an estimated $344K sold.

Federated Hermes first reported a position in QGENF in Q4 2013 and held it in 11 quarters. The position peaked at $917K in Q2 2014. 210 funds tracked by Wall St. Rank hold QGENF as of Q3 2016.

  • Federated Hermes reported no remaining QIAGEN NV position as of Q3 2016 after selling out during the quarter.
  • Federated Hermes sold 15,793 QIAGEN NV shares in Q3 2016, an estimated $344K.
  • Federated Hermes first reported a position in QIAGEN NV in Q4 2013 and held it in 11 quarters.
  • Federated Hermes's QIAGEN NV position peaked at $917K in Q2 2014.
  • 210 funds tracked by Wall St. Rank held QIAGEN NV as of Q3 2016.

Based on Federated Hermes's 13F filing for Q3 2016, filed 10 Nov 2016.